Chiome Bioscience
4583
EURASIA TRAVEL
9376
Btm
5247
And Factory
7035
Beat Holdings
9399
(FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | (Q1)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | -10.78%4.61B | -5.07%1.23B | -11.54%1.17B | -13.56%1.12B | -13.05%1.09B | 4.54%5.16B | -3.76%1.3B | -2.01%1.32B | 6.88%1.3B | 21.22%1.25B |
Cost of revenue | -12.11%3.5B | -6.48%944.09M | -13.98%875.27M | -14.48%848.2M | -13.62%830.48M | 5.85%3.98B | -2.83%1.01B | -2.46%1.02B | 10.65%991.78M | 22.94%961.43M |
Gross profit | -6.30%1.11B | -0.14%289.66M | -3.30%291.05M | -10.55%272.07M | -11.13%256.18M | 0.38%1.18B | -6.87%290.06M | -0.48%300.99M | -3.80%304.17M | 15.81%288.26M |
Operating expense | 0.87%1.07B | 5.71%273.53M | 1.50%274.05M | 1.85%266.44M | -5.31%257.94M | -0.47%1.06B | -8.02%258.75M | 3.46%270M | 0.76%261.59M | 2.48%272.41M |
Operating profit | -69.35%37.01M | -48.46%16.14M | -45.16%17M | -86.77%5.63M | -111.11%-1.76M | 8.50%120.73M | 3.86%31.31M | -25.25%30.99M | -24.76%42.58M | 193.66%15.85M |
Net non-operating interest income (expenses) | 46.56%-1.1M | 46.63%-206K | 46.14%-258K | 51.36%-287K | 42.11%-345K | 25.66%-2.05M | 37.13%-386K | 36.47%-479K | 7.96%-590K | 20.53%-596K |
Non-operating interest income | -46.81%25K | -62.50%9K | -81.82%2K | 10.00%11K | 50.00%3K | -55.24%47K | 140.00%24K | 117.74%11K | -90.91%10K | -95.74%2K |
Non-operating interest expense | -46.57%1.12M | -47.56%215K | -46.94%260K | -50.33%298K | -41.81%348K | -26.75%2.1M | -34.29%410K | -29.19%490K | -20.11%600K | -24.97%598K |
Net investment income | -143.01%-1.64M | -129.30%-986K | -70.08%953K | -446.79%-3.3M | 1,594.00%1.69M | 458.04%3.81M | -46.76%-430K | 1,879.33%3.19M | 427.93%951K | 133.22%100K |
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | 79.37%-758K | 0 | 170.61%197K | 0 | 71.88%-955K | -890.57%-3.68M | 0 | -2.20%-279K | 0 | -916.77%-3.4M |
Income from associates and other participating interests | 0 | 339.13%55K | 0 | -233.33%-40K | 60.53%-15K | 91.82%-113K | -15.00%-23K | -150.00%-40K | 91.24%-12K | 96.86%-38K |
Special income (charges) | -1,607.58%-3.98M | -4.4M | 0 | 419K | 0 | 102.96%264K | 0 | -70.59%190K | 0 | -95.54%74K |
Less:Other special charges | 5.68%-249K | --170K | --0 | ---- | ---- | -102.96%-264K | --0 | 70.59%-190K | --0 | 95.54%-74K |
Less:Write off | --4.23M | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
Other non-operating income (expenses) | -122.20%-789K | -54.90%161K | 133.33%84K | -148.35%-570K | -123.41%-464K | -23.37%3.55M | 188.37%357K | -98.62%36K | 38.22%1.18M | 24.97%1.98M |
Income before tax | -76.54%28.74M | -65.10%10.76M | -46.52%17.97M | -95.80%1.85M | -113.20%-1.85M | 20.81%122.51M | 72.96%30.83M | -22.72%33.61M | -21.76%44.11M | 185.88%13.97M |
Income tax | -40.99%24.62M | -74.93%2.08M | 24.92%15.47M | -50.17%7.69M | -111.00%-617K | 115.15%41.72M | 375.43%8.3M | 29.00%12.38M | -18.73%15.43M | 151.28%5.61M |
Net income | -94.90%4.12M | -61.49%8.68M | -88.20%2.51M | -120.35%-5.84M | -114.67%-1.23M | -1.50%80.79M | 40.11%22.53M | -37.38%21.22M | -23.29%28.68M | 256.86%8.36M |
Net income continuous operations | -94.90%4.12M | -61.48%8.68M | -88.20%2.5M | -120.35%-5.84M | -114.68%-1.23M | -1.50%80.79M | 40.11%22.53M | -37.37%21.22M | -23.30%28.68M | 256.85%8.36M |
Noncontrolling interests | -13.14%820K | 66.03%347K | -66.87%111K | -6.50%230K | -14.29%132K | 816.50%944K | 128.71%209K | 15.92%335K | -61.68%246K | 254.00%154K |
Net income attributable to the company | -95.87%3.3M | -62.68%8.33M | -88.53%2.4M | -121.34%-6.07M | -116.56%-1.36M | -2.53%79.85M | 32.79%22.32M | -37.83%20.89M | -22.63%28.43M | 256.91%8.21M |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | -95.87%3.3M | -62.68%8.33M | -88.53%2.4M | -121.34%-6.07M | -116.56%-1.36M | -2.53%79.85M | 32.79%22.32M | -37.83%20.89M | -22.63%28.43M | 256.91%8.21M |
Gross dividend payment | ||||||||||
Basic earnings per share | -95.88%2.06 | -62.71%5.21 | -88.61%1.49 | -121.24%-3.79 | -116.50%-0.85 | -2.76%50.04 | 32.54%13.97 | -38.01%13.08 | -22.80%17.84 | 256.53%5.15 |
Diluted earnings per share | -95.88%2.05 | -62.52%5.2056 | -88.55%1.49 | -121.42%-3.7933 | -116.60%-0.85 | -2.59%49.73 | 32.41%13.89 | -37.84%13.01 | -23.35%17.71 | 255.62%5.12 |
Dividend per share | 0.00%16 | 0.00%16 | 0 | 0 | 0 | 33.33%16 | 33.33%16 | 0 | 0 | 0 |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |